Vera Bradley, Inc. (NASDAQ:VRA) Q3 2025 Results Conference Call December 11, 2024 9:30 AM ET
Company Participants
Mark Dely - Chief Administrative Officer
Jackie Ardrey - Chief Executive Officer
Michael Schwindle - Chief Financial Officer
Conference Call Participants
Eric Beder - SCC Research
Daniel Harriman - Sidoti & Company
Operator
Greetings. Welcome to the Vera Bradley Third Quarter Fiscal 2025 Earnings Conference Call. At this time all participants are in listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions]. As a reminder, this conference is being recorded.
It is now market pleasure to introduce your host, Mark Dely, Chief Administrative Officer. Thank you, you may begin.
Mark Dely
Good morning and welcome everyone. I'd like to thank you for joining us for today's call. Some of the statements made during our prepared remarks in response to your questions may constitute forward-looking statements made pursuant to and within the meaning of the Safe Harbor provisions of the Private Securities litigation reform act of 1995 as amended. Such forward-looking statements are subject to both known and unknown risks and uncertainties that could cause actual results to differ materially from those, that we expect.
Please refer to today's press release and the company's most recent Form 10-K filed with the SEC for a discussion of known risks and uncertainties. Investors should not assume that, the statements made during the call will remain operative at a later time. We undertake no obligation to update any information discussed on today's call.
I will now turn the call over to Vera Bradley CEO, Jackie Ardrey, Jackie?
Jackie Ardrey
Thanks, Mark. Good morning, everyone and thank you for joining us on today's call. The third quarter was extremely challenging, as we remained in the early stages of project restoration, our strategic initiative to transform our business model and transition
- Read more current VRA analysis and news
- View all earnings call transcripts